These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 12355386
1. Has antifungal susceptibility testing come of age? Rex JH, Pfaller MA. Clin Infect Dis; 2002 Oct 15; 35(8):982-9. PubMed ID: 12355386 [Abstract] [Full Text] [Related]
3. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep 15; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
4. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P. J Antimicrob Chemother; 2004 Mar 15; 53(3):526-9. PubMed ID: 14963064 [Abstract] [Full Text] [Related]
7. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM, Weikert-Oliveira Rde C, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA. Microbiol Res; 2008 Mar 15; 163(5):579-85. PubMed ID: 16962755 [Abstract] [Full Text] [Related]
8. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):401-5. PubMed ID: 16831406 [Abstract] [Full Text] [Related]
11. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. Fleck R, Dietz A, Hof H. J Antimicrob Chemother; 2007 Apr 25; 59(4):767-71. PubMed ID: 17293369 [Abstract] [Full Text] [Related]
12. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M, Karaman M. Mikrobiyol Bul; 2004 Apr 25; 38(1-2):91-8. PubMed ID: 15293907 [Abstract] [Full Text] [Related]
13. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A. Int J Antimicrob Agents; 2005 Apr 25; 25(4):321-8. PubMed ID: 15784312 [Abstract] [Full Text] [Related]
14. [The activity of systemic antimycotic drug combinations]. Viudes A, Pemán J, Cantón E, López-Ribot J, Gobernado M. Rev Esp Quimioter; 2001 Mar 25; 14(1):30-9. PubMed ID: 11376347 [Abstract] [Full Text] [Related]
15. The role of antifungal susceptibility testing in the therapy of candidiasis. Hospenthal DR, Murray CK, Rinaldi MG. Diagn Microbiol Infect Dis; 2004 Mar 25; 48(3):153-60. PubMed ID: 15023422 [Abstract] [Full Text] [Related]
18. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT. Antimicrob Agents Chemother; 2005 Feb 25; 49(2):512-7. PubMed ID: 15673726 [Abstract] [Full Text] [Related]
20. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults. Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, Schito AM, Marchese A. Int J Antimicrob Agents; 2007 Feb 25; 29(2):179-84. PubMed ID: 17175140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]